Skip to content

Dr. Rumbaut Joris

Active
Private limited companyfounded 2022active for 3 yearsKerkweg 14, 3370 Boutersem, BelgiumKBO/BCE: BE 0795.356.349
Summary

Dr. Rumbaut Joris has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €234,254 and a net result of €76,727. Equity has been growing by about 70% per year since 2023. Its solvency ranks better than 84% of 3,040 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 23-12-2022 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.339.939.314 3360 Bierbeek, since 23-12-2022
Financial year end
31 December
Peppol
Reachable since 21-10-2026

Board and ownership

Board
Shareholders
  • RUMBAUT Joris Jan Driesdeed of 28-12-2022

Financial position

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€103,189
▼ 1.9%
Turnover
≈ €190,000
estimated
Profit
€76,727
▼ 0.1%
Equity
€234,254
▲ 48.7%
Total assets
€262,333
▲ 39.5%
Score breakdownraises risk2 of the last 3 accounts latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 9.29, cash €182,094Equity €234,254 (89.3% of total assets)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 83% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 89.3% of total assets
Liquidity 100+2
short-term debt 10.4% · cash 69.4%
Profitability 100=
return on assets 29.2%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,173 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025highest value 10-2025: < 0.1%▼ -0.1 percentage points vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €22,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 9.29 (6.85 in 2024), above the usual 1.5. Short-term debt is 10.4% and cash 69.4% of total assets. 10.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 90% on liquidity, 80% on profitability and 80% on growth.

The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 9.29, cash €182,094
NBB · annual accounts
raises risk · 2 of the last 3 accounts late
NBB · filings
lowers risk · Equity €234,254 (89.3% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
on the day
2024
57 days late
2023
61 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 3 accounts on average 39 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 September (3 of the last 3 accounts filed within 57 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
05-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2022.
KBO publications

Key points

  • Positive: Higher solvency than 83% of companies in human healthsector median 59.1% · 3,040 companies 89.3% View
  • Positive: Equity rose in 2025from €157,527 to €234,254 ▲ 48.7% View

Recent changes

  1. · Gazette deed IncorporationFounding capital of €5,000, 100 shares · Founder: RUMBAUT Joris Jan Dries · Appointment: RUMBAUT Joris Jan Dries (director)
All 7 events

Comparable companies

These companies have the same main activity as Dr. Rumbaut Joris: general medical practice (NACE 86210). They are comparable in size and age: total assets between €171,000 and €366,000, founded between 2019 and 2023.

CompanyTotal assetsGross margin
Dr. Rumbaut Joris Boutersem€262,333€103,189
DR. PIL DAVID Lubbeek€305,289€123,707
Docteur CREVIEAUX Julie KRUSKOLIE Binche€325,458€139,239
DOCTEUR NONET Margaux Profondeville€197,812€120,860
Türmchen Eupen€204,117€129,635
ARTSENASSOCIATIE HET LAAR Antwerp€170,931€135,445
DOKTER KAAT PIERREUX Halle€365,750€155,964
Full comparison

Key facts about Dr. Rumbaut Joris

What is the company number of Dr. Rumbaut Joris?
The company number of Dr. Rumbaut Joris is 0795.356.349. The VAT number is the same number with BE in front: BE 0795.356.349.
Where is Dr. Rumbaut Joris based?
The registered office is at Kerkweg 14, 3370 Boutersem.Company details
What does Dr. Rumbaut Joris do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Rumbaut Joris?
Dr. Rumbaut Joris is a private limited company (BV).
When was Dr. Rumbaut Joris founded?
Dr. Rumbaut Joris was founded on 23-12-2022.
Is Dr. Rumbaut Joris still active?
Yes, Dr. Rumbaut Joris is an active enterprise in the KBO register.
What is the turnover of Dr. Rumbaut Joris?
The turnover in financial year 2025 is ≈ €190,000. This figure is estimated from the gross margin of €103,189 and 30 comparable companies (NACE 86210). It probably lies between €150,000 and €230,000.Financials
Is Dr. Rumbaut Joris profitable?
In financial year 2025, Dr. Rumbaut Joris made a profit of €76,727.
Where can I find the annual accounts of Dr. Rumbaut Joris?
Dr. Rumbaut Joris filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Rumbaut Joris due?
Dr. Rumbaut Joris must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.